Two Sigma Securities’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295 Buy
65,609
+47,205
+256% +$316 ﹤0.01% 1657
2026
Q1
$182 Sell
18,404
-163
-0.9% -$2 ﹤0.01% 1593
2025
Q4
$302 Sell
18,567
-9,159
-33% -$231 ﹤0.01% 1409
2025
Q3
$973 Buy
27,726
+9,958
+56% +$482 ﹤0.01% 1288
2025
Q2
$787 Buy
17,768
+232
+1% +$10 ﹤0.01% 1411
2025
Q1
$701 Buy
17,536
+6,525
+59% +$352 ﹤0.01% 1367
2024
Q4
$198 Buy
+11,011
New +$189 ﹤0.01% 1534
2023
Q4
Sell
-24,163
Closed -$367 3074
2023
Q3
$367 Buy
+24,163
New +$831 ﹤0.01% 2856

Other funds holding CELUW

Two Sigma Securities's CELUW Position: Q2 2026 in Review

Two Sigma Securities increased its Celularity Inc (CELUW) stake by 256% in Q2 2026, buying an estimated $316 and bringing the position to 65,609 shares worth $295. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Two Sigma Securities first reported a position in CELUW in Q3 2023 and has held it in 8 quarters since. The position peaked at $973 in Q3 2025. 16 funds tracked by Wall St. Rank hold CELUW as of Q2 2026.

  • Two Sigma Securities held 65,609 shares of Celularity Inc worth $295 as of Q2 2026.
  • Two Sigma Securities bought 47,205 Celularity Inc shares in Q2 2026, an estimated $316.
  • Celularity Inc made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1657 holding.
  • Two Sigma Securities first reported a position in Celularity Inc in Q3 2023 and has held it in 8 quarters since.
  • Two Sigma Securities's Celularity Inc position peaked at $973 in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.